Effect of olfactory training on anosmia of COVID-19
Phase 2
- Conditions
- AnosmiaR43.0oss of smell, Olfactory Rehabilitation.
- Registration Number
- IRCT20200629047953N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Smell disorders caused by COVID-19 during Coronavirus pandemia
Positive Serology of COVID-19
Exclusion Criteria
Diseases causing smell disorders
Drugs causing smell disorders
Sinonasal anatomical disorders
Negative Anti-COVID antibody test
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of Smell Identification Test. Timepoint: Measure theSIT test at the beginning of the study and 90 days after the onset of olfactory rehabilitation. Method of measurement: Iranian SIT.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie olfactory recovery in post-COVID-19 anosmia patients following olfactory training interventions?
How does olfactory training compare to standard-of-care therapies for olfactory rehabilitation in R43.0 disease subtypes?
Are there specific biomarkers that correlate with improved olfactory function after olfactory training in SARS-CoV-2-induced anosmia?
What are the potential adverse events associated with olfactory training protocols in post-viral olfactory dysfunction patients?
What combination approaches or alternative therapies are being explored alongside olfactory training for treating olfactory loss in viral infections?